More About Becky
Becky Pferdehirt is an investing partner on the Bio + Health team. She focuses on early stage companies building technology platforms for therapeutic discovery and development. She is involved in companies like: Cartography Bio, Vicinitas Therapeutics, Scribe Therapeutics, BioAge Labs, Genesis Therapeutics, Inceptive, GC Therapeutics, Trotana, Patch Bio, Stipple Bio, Siduma Therapeutics.
Prior to joining Andreessen Horowitz, Becky worked at Amgen where she most recently led business development efforts for therapeutic platform partnerships. Before moving to BD Becky was a research scientist in Amgen R&D, focused on cell and gene therapy technology innovation.
Becky completed her postdoctoral education at Genentech, studying cancer cell biology and proteomics. She holds a PhD in Molecular and Cellular Biology from UC Berkeley and a BS in Biology from MIT. She grew up in the midwest across Chicago and Madison, and in her free time enjoys spending time with her two daughters, skiing and kiteboarding.
